Evolent Health, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2024 and Raises Earnings Guidance for the Full Year Full Year Ending December 31, 2024
May 10, 2024 at 01:40 am IST
Share
Evolent Health, Inc. provided earnings guidance for the second quarter ending June 30, 2024 and raises earnings guidance for the full year full year ending December 31, 2024. For the three months ended June 30, 2024, revenue is expected to be in the range of approximately $625.0 million to $645.0 million.
For year ending December 31, 2024, revenue is expected to be in the range of approximately $2.53 billion to $2.60 billion.
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
Evolent Health, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2024 and Raises Earnings Guidance for the Full Year Full Year Ending December 31, 2024
EVOLENT HEALTH, INC. 
